About This Study
The purpose of this study is to evaluate the safety and effectiveness of an investigational hydrocortisone acetate 90 mg suppository formulation administered with the Sephure applicator for the treatment of moderate to severe ulcerative colitis of the rectum
Who is eligible to participate?
Men and women over the age of 18 are eligible to participate in this study.
Confirmed diagnosis of ulcerative colitis confined to the rectum at time of enrollment.
Inclusion Criteria:
Click Here
Exclusion Criteria:
Click Here
To learn more about what’s involved in the study, and what study participants will need to do, click here
Want to know if you can participate? click here
Currently recruiting at clinical research sites around the world.
To find a research site near you, please click here
Cristcot HCA LLC 9 Damonmill Square, Suite 4A, Concord, MA 01742 USA
privacy policy | terms of use
cessa is the name of an ongoing clinical trial for people with ulcerative colitis.
It is not a commercially available treatment.
If you are experiencing symptoms related to IBD, contact your gastroenterologist.